Previous 10 | Next 10 |
PLx Pharma (PLXP +10.7%) has gained more than a tenth in value after Raymond James upgraded the stock to Outperform from Market Perform, citing the recent weakness in its share price. The price target at $14 per share, implying a premium of ~70.5% to the last close, reflects a DCF model, ...
SPARTA, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potentia...
PLx Pharma Inc. (PLXP) Q3 2021 Earnings Conference Call November 12, 2021 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Natasha Giordano - President and Chief Executive Officer Rita O’Connor - Chief Financial Officer Conference Call Participants Leland Gershell - Opp...
PLx Pharma (NASDAQ:PLXP): Q3 Non-GAAP EPS of -$0.37 beats by $0.09; GAAP EPS of -$0.80 misses by $0.34. Revenue of $6.6M beats by $2.5M. Press Release For further details see: PLx Pharma EPS beats by $0.09, beats on revenue
-- Results demonstrate strong execution of initial phase of VAZALORE commercial launch, including shipments to 30,000+ stores nationwide and e-commerce sites -- -- Reported net revenue of $6.6 million in third quarter 2021 reflecting initial sales of VAZALORE -- -- Third quarter 2...
-- VAZALORE 81 mg shows fast bioavailability, absorption, and platelet inhibition -- -- VAZALORE 81 mg has pharmacokinetic and pharmacodynamic profiles consistent with VAZALORE 325 mg -- -- Findings presented at TCT meeting earlier today -- SPARTA, N.J., Nov. 04, 2021 (GLOBE...
SPARTA, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform that has the potential ...
PLx Pharma (NASDAQ:PLXP) announces a launch update for its lead product Vazalore. Vazalore is a pain medication that delivers aspirin differently from plain and enteric coated aspirin products. The company has supplied three stock keeping units ((SKUs)) of Vazalore into mo...
-- Supplied VAZALORE to 30,000+ stores nationwide and e-commerce sites -- -- Launch in line with expectations and exceptionally positive feedback from consumers and healthcare professionals received -- -- Third quarter 2021 earnings and business update conference call scheduled for ...
While the S&P 500 index added ~1.8% gain over the week, its healthcare constituents underperformed with a ~0.8% rise yet, recording their first weekly gain in more than a month. Dragged down by pharma stocks, the sector became the second-worst performer in the index for ano...
News, Short Squeeze, Breakout and More Instantly...
SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE ® ,...
SPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to...
2023-04-11 06:00:00 ET 3 Tips for Finding Winning Penny Stocks in 2023 The potential for exponential growth has made penny stocks a favorite among investors seeking to capitalize on undervalued, up-and-coming companies. Penny stocks , typically defined as those trading below $5 per ...